Christopher Capelli
Gründer bei SOLITON, INC.
Aktive Positionen von Christopher Capelli
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SOLITON, INC. | Direktor/Vorstandsmitglied | 01.02.2021 | - |
| Gründer | 01.02.2021 | - | |
| Corporate Officer/Principal | 01.02.2021 | - | |
| AUTONOMIX MEDICAL, INC. | Direktor/Vorstandsmitglied | 01.09.2023 | - |
| Independent Dir/Board Member | 01.09.2023 | - |
Karriereverlauf von Christopher Capelli
Ehemalige bekannte Positionen von Christopher Capelli
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| The University of Texas at Austin | Corporate Officer/Principal | 01.03.2005 | 01.08.2014 |
| University of Pittsburgh | Corporate Officer/Principal | 01.03.2001 | 01.02.2005 |
| Biointerface Technologies, Inc. | Gründer | 01.01.1987 | 01.01.1998 |
| Präsident | 01.01.1987 | 01.01.1998 |
Ausbildung von Christopher Capelli
| Massachusetts Institute of Technology | Undergraduate Degree |
| University of Wisconsin School of Medicine & Public Health | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Founder | 2 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AUTONOMIX MEDICAL, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Soliton, Inc. (Texas)
 Soliton, Inc. (Texas) Medical SpecialtiesHealth Technology Soliton, Inc. is a medical development company, which engages in the development of healthcare technological devices for medical and cosmetic treatments. Its technology platform include Rapid Acoustic Pulse, a device uses rapid pulses of designed acoustic shockwaves to disrupt cellular structures in the dermal and subdermal tissue. The firm is also in the pre-revenue stage with its first products being developed for the removal of tattoos and the reduction of cellulite. The company was founded by Walter V. Klemp and Christopher Capelli on March 27, 2012 and is headquartered in Houston, TX. | Health Technology |
| Biointerface Technologies, Inc. |
- Börse
- Insiders
- Christopher Capelli
- Erfahrung
